马来西亚老年人中外围神经病变的患病率和决定因素:基于社区的横截面研究的见解
Li Huan1, Siew Mooi Ching2,3,4, Siok Fuang Liong5
1Institute of Medical Technology, Shaanxi Energy Institute, Xianyang, China.
Journal of family medicine and primary care
|March 12, 2026
概括
周围神经病变 (PN) 影响了60.9%的老年马来西亚人. 糖尿病,年龄增长和男性性别是PN的重要风险因素,需要有针对性的查和早期干预.
科学领域:
- 神经学 神经学
- 流行病学 流行病学
背景情况:
- 周围神经病变 (PN) 是一种广泛的神经疾病,在全球老年人群中患病率越来越高.
- 马来西亚面临着一个重大的公共卫生挑战,其老龄化人口中PN的负担很高.
研究的目的:
- 确定马来西亚老年人中外围神经病变 (PN) 的患病率.
- 确定与这一队列中PN发展相关的关键人口统计和临床因素.
主要方法:
- 在7家马来西亚零售药店进行了横截面研究.
- 数据收集涉及社会人口统计信息,病史和使用生物度仪进行PN评估.
- 使用多重逻辑回归分析来确定与PN相关的因素.
主要成果:
- 在老年马来西亚人中,PN的患病率为60.9%.
- 糖尿病显著增加了患PN的几率 (AOR = 3.216).
- 晚年 (OR=1.109每年) 和男性性别 (AOR=1.731) 也与更高的PN概率有关.
结论:
- 马来西亚老年人中PN的高患病率凸显了针对性查计划的迫切需要.
- 年龄,男性性别和糖尿病被确定为PN发展的重要风险因素.
- 定期对老年人进行PN查对于预防长期并发症至关重要.
相关概念视频
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
575
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
575
Pharmacodynamics in Geriatric Patients: Effects of Age
307
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
307
Peripheral Artery Disease IV: Nursing Management
524
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
524
Peripheral Artery Disease I: Introduction
542
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
542
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
785
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
785
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
302
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
302


